Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arnica is a perennial herb most commonly referring to the species *Arnica montana*, but also includes related species such as *Arnica chamissonis* and others. It has been widely used in folk and homeopathic medicine for conditions like bruises, sprains, muscle pain (myalgia), joint pain (arthralgia), inflammation and wound healing[2][4][7]. The primary active constituents are sesquiterpene lactones which have anti-inflammatory properties. Mechanistically these compounds inhibit binding of transcription factors AP-1 and NF-κB to DNA—key regulators of inflammatory gene expression—and suppress matrix metalloproteinases MMP1 and MMP13 involved in cartilage destruction[8]. Topical preparations are considered the safest form; oral use is associated with significant toxicity risks including gastroenteritis and cardiac effects[2][5]. There is some evidence that topical arnica gel may reduce pain from osteoarthritis comparably to ibuprofen[3], but overall clinical evidence remains limited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on arnica.